397 related articles for article (PubMed ID: 15097439)
1. Discordant erythrocyte sedimentation rate and C-reactive protein in children with inflammatory bowel disease taking azathioprine or 6-mercaptopurine.
Barnes BH; Borowitz SM; Saulsbury FT; Hellems M; Sutphen JL
J Pediatr Gastroenterol Nutr; 2004 May; 38(5):509-12. PubMed ID: 15097439
[TBL] [Abstract][Full Text] [Related]
2. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
Hande S; Wilson-Rich N; Bousvaros A; Zholudev A; Maurer R; Banks P; Makrauer F; Reddy S; Burakoff R; Friedman S
Inflamm Bowel Dis; 2006 Apr; 12(4):251-7. PubMed ID: 16633046
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease.
Belaiche J; Desager JP; Horsmans Y; Louis E
Scand J Gastroenterol; 2001 Jan; 36(1):71-6. PubMed ID: 11218242
[TBL] [Abstract][Full Text] [Related]
4. Mean Corpuscular Volume to White Blood Cell Ratio for Thiopurine Monitoring in Pediatric Inflammatory Bowel Disease.
Kandavel P; Eder SJ; Newman NE; Waljee AK; Whitfield EP; Adler J
J Pediatr Gastroenterol Nutr; 2019 Jul; 69(1):88-94. PubMed ID: 30747813
[TBL] [Abstract][Full Text] [Related]
5. Increased dosing requirements for 6-mercaptopurine and azathioprine in inflammatory bowel disease patients six years and younger.
Grossman AB; Noble AJ; Mamula P; Baldassano RN
Inflamm Bowel Dis; 2008 Jun; 14(6):750-5. PubMed ID: 18266236
[TBL] [Abstract][Full Text] [Related]
6. Erythrocyte mean corpuscular volume as a surrogate marker for 6-thioguanine nucleotide concentration monitoring in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine.
Thomas CW; Lowry PW; Franklin CL; Weaver AL; Myhre GM; Mays DC; Tremaine WJ; Lipsky JJ; Sandborn WJ
Inflamm Bowel Dis; 2003 Jul; 9(4):237-45. PubMed ID: 12902847
[TBL] [Abstract][Full Text] [Related]
7. Clinical Value of Mercaptopurine After Failing Azathioprine Therapy in Patients With Inflammatory Bowel Disease.
Meijer B; Seinen ML; Leijte NN; Mulder CJ; van Bodegraven AA; de Boer NK
Ther Drug Monit; 2016 Aug; 38(4):463-70. PubMed ID: 27158876
[TBL] [Abstract][Full Text] [Related]
8. [Thiopurine methyltransferase activity and myelosuppression in inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine].
Gisbert JP; Luna M; Maté J; González-Guijarro L; Cara C; Pajares JM
Med Clin (Barc); 2003 Jun; 121(1):1-5. PubMed ID: 12812701
[TBL] [Abstract][Full Text] [Related]
9. IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel diseases.
Meuwissen SG; Ewe K; Gassull MA; Geboes K; Jewell D; Pallone F; Rachmilewitz D; Rask-Madsen J; Riddell BH; Sandborn BJ; Schmuck ML
Eur J Gastroenterol Hepatol; 2000 Jan; 12(1):13-8. PubMed ID: 10656204
[TBL] [Abstract][Full Text] [Related]
10. Azathioprine: state of the art in inflammatory bowel disease.
Sandborn WJ
Scand J Gastroenterol Suppl; 1998; 225():92-9. PubMed ID: 9515759
[TBL] [Abstract][Full Text] [Related]
11. Reassuring results on birth outcomes in children fathered by men treated with azathioprine/6-mercaptopurine within 3 months before conception: a nationwide cohort study.
Nørgård BM; Magnussen B; Larsen MD; Friedman S
Gut; 2017 Oct; 66(10):1761-1766. PubMed ID: 27456154
[TBL] [Abstract][Full Text] [Related]
12. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
13. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease.
Kirschner BS
Gastroenterology; 1998 Oct; 115(4):813-21. PubMed ID: 9753482
[TBL] [Abstract][Full Text] [Related]
14. Concomitant use of azathioprine/6-mercaptopurine decreases the risk of anti-TNF-induced skin lesions.
Soh JS; Yun WJ; Kim KJ; Won CH; Park SH; Yang DH; Ye BD; Byeon JS; Myung SJ; Yang SK; Kim JH
Inflamm Bowel Dis; 2015 Apr; 21(4):832-9. PubMed ID: 25789922
[TBL] [Abstract][Full Text] [Related]
15. Leukopenia predicts remission in patients with inflammatory bowel disease and Behcet's disease on thiopurine maintenance.
Park MS; Kim DH; Kim DH; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH
Dig Dis Sci; 2015 Jan; 60(1):195-204. PubMed ID: 25239495
[TBL] [Abstract][Full Text] [Related]
16. Normal thiopurine methyltransferase levels do not eliminate 6-mercaptopurine or azathioprine toxicity in children with inflammatory bowel disease.
Kader HA; Wenner WJ; Telega GW; Maller ES; Baldassano RN
J Clin Gastroenterol; 2000 Jun; 30(4):409-13. PubMed ID: 10875470
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of tolerance to mercaptopurine in patients with inflammatory bowel disease and gastrointestinal intolerance to azathioprine.
Bastida G; Alvarez-Sotomayor D; Aguas M; Iborra M; Del Hoyo J; Béjar-Serrano S; Garrido-Marín A; Valero-Pérez E; Nos P
Gastroenterol Hepatol; 2024 May; 47(5):473-480. PubMed ID: 38072359
[TBL] [Abstract][Full Text] [Related]
18. Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory bowel disease.
Ramakrishna J; Langhans N; Calenda K; Grand RJ; Verhave M
J Pediatr Gastroenterol Nutr; 1996 Apr; 22(3):296-302. PubMed ID: 8708884
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of AZA/6-MP treatment in children with IBD is necessary.
Dubinsky MC
Inflamm Bowel Dis; 2003 Nov; 9(6):386-8; discussion 392-3. PubMed ID: 14671488
[No Abstract] [Full Text] [Related]
20. Discordance between erythrocyte sedimentation rate and C-reactive protein measurements: clinical significance.
Costenbader KH; Chibnik LB; Schur PH
Clin Exp Rheumatol; 2007; 25(5):746-9. PubMed ID: 18078625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
